Loading organizations...
Key people at Genetics Institute, Inc.
Founded in December 1980 by Mark Ptashne, Thomas Maniatis, and J David, Genetics Institute was a biotechnology company based in Cambridge, Massachusetts, focused on commercializing recombinant DNA technology. Originating from biological laboratory research conducted by scientists at Harvard University, the firm utilized genetic engineering to develop pharmaceutical treatments, including products stimulating red blood cells for patients with severe anemia. Operating as a publicly traded entity on the NASDAQ, the enterprise scaled its commercial operations to generate $88 million in annual sales while employing a specialized workforce of 870 individuals. After initially securing $6 million in venture capital funding to build laboratories, the organization expected to achieve its first profitable quarter by August 1991. In September 1991, the business executed a major corporate transaction by selling a 60% ownership stake to American Home Products for $666 million.
Key people at Genetics Institute, Inc.
Genetics Institute, Inc. was an early Cambridge‑area biotechnology company (founded 1980) that researched, developed and commercialized recombinant protein therapeutics; it was best known for hemophilia and hematopoietic growth‑factor programs and was acquired by Wyeth in the mid‑1990s[2][1].
High‑Level Overview
Origin Story
Core Differentiators
Role in the Broader Tech / Biotech Landscape
Quick Take & Future Outlook (historical forward‑looking)
If you’d like, I can: